Open Nav

Lauren Sciences LLC

  • Susan Rosenbaum, Lauren Sciences LLC

Partnering/Financing

  • Date:Wednesday, October 17
  • Time:3:30 PM - 3:45 PM
  • Room:Elizabethan A
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Lauren Sciences LLC leads in Neuroscience as New York biotech committed to development of its novel V-Smart® platform to create robust pipeline of transformative V-Smart® Nanomedicines, consisting of CNS-active drugs that normally do not cross BBB, for Parkinson's, ALS, GBM, Alzheimer's, etc. V-Smart® Nanomedicines encapsulate non-brain penetrant therapeutic agents, “macro” target brain and cross BBB, “micro” target and deliver to specific brain sites, selectively release at target sites, are administered non-invasively. V-Smart® Nanomedicines are revolutionary, game changers, disease-modifying drugs. V-Smart® breakthrough innovation is the global solution for CNS. Lauren Sciences has: 11 foundation grant awards; 6 pre-clinical pipeline products; 18 peer-reviewed journal publications; 30 research presentations; 7 scientific meeting posters; 10 patent family portfolio estate; laboratories/research team in Israel, where V-Smart® technology was invented.
  • Company Website:www.laurensciences.com
  • Company HQ City:New York
  • Company HQ Country:United States
  • Company HQ State:New York                    
  • CEO/Top Company Official:Susan Rosenbaum
  • Main Therapeutic Focus:CNS/Neurological
  • Lead Product in Development :LAUR-101 (V-Smart® Nanomedicine for Parkinson's)
  • Development Phase of Primary Product:Pre-Clinical
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :6
  • Additional Information/Comments:Lauren Sciences LLC leads in Neuroscience as New York biotech committed to development of its novel V-Smart® platform to create robust pipeline of transformative V-Smart® Nanomedicines, consisting of CNS-active drugs that normally do not cross BBB, for Parkinson's, ALS, GBM, Alzheimer's, etc. V-Smart® Nanomedicines encapsulate non-brain penetrant therapeutic agents, “macro” target brain and cross BBB, “micro” target and deliver to specific brain sites, selectively release at target sites, are administered non-invasively. V-Smart® Nanomedicines are revolutionary, game changers, disease-modifying drugs. V-Smart® breakthrough innovation is the global solution for CNS. Lauren Sciences has: 11 foundation grant awards; 6 pre-clinical pipeline products; 18 peer-reviewed journal publications; 30 research presentations; 7 scientific meeting posters; 10 patent family portfolio estate; laboratories/research team in Israel, where V-Smart® technology was invented.
  • Total Amount Raised to Date, In All Rounds:$10,000,000
Speakers
Susan Rosenbaum
Lauren Sciences LLC
Back